Bell Biosystems, Inc.
SAN FRANCISCO, CA · Founded 2009 · CIK 0001550379 · Biotech · Defunct
Magnetoendosymbionts (MEs) as living MRI contrast agents for cell tracking and viability monitoring in transplanted stem cells
bellbiosystems.com →- Grants
- $1.7M
- 3 awards
- Sector median: 1
- Raised
- $2.4M
- 3 Form D · Jan 2014
- 153 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 35
- 20 granted · 15 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2011201220132014201520162017
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised· 1 of 2 same day | Form D · SEC | $250,000 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $120,000 | |
| Private capital raised | Form D · SEC | $2,058,230 | |
| Federal grant | Department of Health and Human Services · Phase I · Single Cell Spatiotemporal and Functional Reporting using Magneto-Endosymbionts | $224,679 | |
| Federal grant | Department of Health and Human Services · Phase II · Tracking cardiac engraftment and viability of MiPSC by MRI | $983,354 | |
| Federal grant | Department of Health and Human Services · Phase II · Tracking cardiac engraftment and viability of MiPSC by MRI | $479,285 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1517 | Virscio Inc | — | — |
| 1518 | Moonwalk Biosciences | — | $110M |
| 1519 | DEGROME THERAPEUTICS, INC. | — | — |
| 1520 | Bell Biosystems, Inc. | — | $2.4M |
| 1521 | MOSAIC ENGINEERING LLC | — | — |
| 1522 | SHY THERAPEUTICS, LLC | — | — |
| 1523 | Varda Space | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Caleb BellDirector · Executive Officer
- Daniel BellDirector · Executive Officer
- Stuart BermanDirector
- Bell CalebDirector · Executive Officer
- Bell, III CalebDirector · Executive Officer
- Christian OlgaardDirector
- Una RyanDirector
- Gil Van BokkelenDirector
Patents
- Host Cells with Artificial Endosymbiontsgranted
- Host Cell Modification with Artificial Endosymbiontsapplication
- Host Cell Modification with Artificial Endosymbiontsgranted
- Host Cells With Artificial Endosymbiontsgranted
- Host Cells with Artificial Endosymbiontsgranted
- Eukaryotic Cells with Artificial Endosymbionts for Multimodal Detectionapplication
- Host Cells With Artificial Endosymbiontsgranted
- Systems for Making Host Cells with Artificial Endosymbiontsapplication
- Eukaryotic Cells with Artificial Endosymbionts for Multimodal Detectiongranted
- Host Cell Modification with Artificial Endosymbiontsgranted
- Eukaryotic Cells With Artificial Endosymbionts For Monitoring The Duration And Persistence Of The Eukaryotic Cellapplication
- Host Cells with Artificial Endosymbiontsgranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.